Insiders · Profile

O'Donnell Niall

Director at OnKure Therapeutics · Director at SPRUCE BIOSCIENCES · Director at Mirum Pharmaceuticals. Filing since 22 Jul 2019. CIK 0001780235

Company
Date
Role
Action
Shares
Amount
Of holding
8 May 2023
Director
Bought
125,000
$1.00M
6.1%
16 Feb 2023
Director
Bought
630,400
$2.00M
90.6%
15 Nov 2022
Director
Sold, plan not stated
93,770
$1.85M
5.5%
14 Nov 2022
Director
Sold, plan not stated
32,109
$629.42K
1.8%
11 Nov 2022
Director
Sold, plan not stated
174,121
$3.48M
9.1%
13 Apr 2021
Director
Bought
200,000
$3.00M
10.7%
14 Oct 2020
Director
Bought
250,000
$3.75M
56.1%
22 Jul 2019
Director
Bought
300,000
$4.50M
18.5%
8 decisions on file.